Skip to content

A-Z pharma

Active Risk: not assessed Private limited companyfounded 2018active for 8 yearsAristide Briandlaan 5, 1070 AnderlechtKBO/BCE: BE 0689.800.949

Timeline

17 events since 2018

The 2026 accounts are due by 31-07-2027.

2026
Annual accounts 2025 filed NBBabbreviated format · 5 days late
2025
Registered in the Peppol Directory Reachable for e-invoices through 0208:0689800949
Annual accounts 2024 filed PDFfull format · 20 days late
changes role from manager to directorDischarge granted to · General meeting of 20-01-20256 points ▸
  • General meeting of 20-01-2025
  • resigns as manager
  • Discharge granted to
  • appointed as director, not named in the articles
  • The registered office is at boulevard Aristide Briand 5, 1070 Anderlecht
  • Power of attorney granted to
  • The deed holds 6 more points.

Open the deed in the Belgian Official Gazette

2024
Annual accounts 2023 filed PDFfull format · 21 days late
2023
Annual accounts 2022 filed PDFfull format · 30 days before the deadline
2022
Highest result from 2018 to 2025 net €235,016 ▲666% The net result of €235,016 is the highest of those years.
Liquidity doubles current ratio 2.54 The current ratio rises from 1.24 to 2.54. Short-term debt falls from €256,474 to €161,112.
Equity above €200,000 equity €431,437 ▲120% Equity rises from €196,421 to €431,437.
Annual accounts 2021 filed PDFfull format · 32 days late
2021
Annual accounts 2020 filed PDFfull format
Annual accounts 2020 filed PDFmicro format · 33 days before the deadline
2020
Annual accounts 2019 filed PDFfull format · 31 days before the deadline
2019
Equity above €100,000 equity €111,984 ▲249% With a profit in every financial year since 2018, equity grows to €111,984.
Annual accounts 2018 filed PDFfull format · 26 days before the deadline
2018
First establishment Aristide Briandlaan 5, Anderlecht
IncorporationFounding capital of €18,600, 186 shares · Founded by · appointed as manager · published on 07-02-20184 points ▸
  • Founded by
  • The capital is €18,600, divided into 186 shares
  • The founding capital is €18,600, divided into 186 shares
  • appointed as manager, not named in the articles
  • The deed holds 3 more points.

Open the deed in the Belgian Official Gazette

Financial milestones sit on the financial year-end date, not the filing date.

Sources: Publications in the Belgian Official GazetteFilings with the National Bank

History

A-Z pharma was incorporated on 5 February 2018 by one private individual, with a starting capital of €18,600.12 is director of the company, appointed by deed of 27-01-2025.3 Total assets rose from €937,870 in 2018 to €1.3m in 2025.4

  1. 1KBO register
  2. 2Belgian Official Gazette, 07-02-2018
  3. 3Belgian Official Gazette, 27-01-2025
  4. 4National Bank, annual accounts 2018 and 2025

Next steps